Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter.
Keep Reading →
February 2 - Hedge Fund Investor Letters, News - Comments
Bernzott Capital Advisors, an investment management firm, published its “US Small Cap Value Fund” fourth-quarter 2022 investor letter, a copy of which can be downloaded here...
Keep Reading →
January 23 - Hedge Fund Investor Letters, News - Comments
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
January 20 - Hedge Fund Investor Letters, News - Comments
The global diabetes market is segmented based on the type, drug class, and devices used to treat the condition.
Keep Reading →
November 27 - Hedge Funds, News - Comments
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
November 15 - Hedge Fund Investor Letters, News - Comments
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” second quarter 2022 investor letter – a copy of which can be...
Keep Reading →
October 3 - Hedge Fund Investor Letters, News - Comments
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
September 30 - Hedge Fund Investor Letters, News - Comments
Bernzott Capital Advisors, an investment management firm, published its “US Small Cap Value Fund” first quarter 2022 investor letter – a copy of which can be downloaded ...
Keep Reading →
May 12 - Hedge Fund Investor Letters, News - Comments
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded...
Keep Reading →
February 27 - Hedge Fund Investor Letters, News - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
December 17 - Hedge Funds, News - Comments
In this article, we discuss the 15 best stocks to buy for 2022 according to analysts.
Keep Reading →
December 6 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
October 26 - Hedge Funds, News - Comments
In this article you are going to find out whether hedge funds think Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a good investment right now.
Keep Reading →
July 19 - Hedge Funds, News - Comments
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
April 22 - Hedge Funds, News - Comments
Artisan Partners Limited Partnership, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2020 investor letter – a copy ...
Keep Reading →
March 19 - Hedge Fund Investor Letters, News - Comments
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
September 28 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
July 17 - Hedge Funds, News - Comments
In this article you are going to find out whether hedge funds think Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a good investment right now.
Keep Reading →
June 16 - Hedge Funds, News - Comments
First Eagle Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below.
Keep Reading →
May 29 - Hedge Fund Investor Letters, News - Comments
Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below.
Keep Reading →
May 11 - Hedge Fund Investor Letters, News - Comments
We hate to say this but, we told you so.
Keep Reading →
March 29 - Hedge Funds, News - Comments
BOSTON (Reuters) - Citadel, the Chicago-based hedge fund giant led by billionaire Ken Griffin, has so far weathered the coronavirus market storm well, turning a slight profit ...
Keep Reading →
March 24 - Hedge Funds, Insider Trading - Comments
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Keep Reading →
December 6 - Hedge Funds, News - Comments
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.
Keep Reading →
October 23 - Hedge Funds, News - Comments
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and ...
Keep Reading →
June 11 - Hedge Funds, News - Comments
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Keep Reading →
April 30 - Hedge Funds, News - Comments
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Keep Reading →
December 14 - Hedge Funds, News - Comments
"U.S. equities traded higher on Friday as concerns about Donald Trump's presidency recede for the time being.
Keep Reading →
May 19 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
Keep Reading →
December 9 - Hedge Funds, News - Comments
No major moves in the US stock market this Wednesday morning, as investors digest retail earnings reports and are keeping an eye on oil prices.
Keep Reading →
August 10 - Earnings Report, News - Comments
The markets can’t seem to catch a break in 2016; on Wednesday, all major U.S stock indexes continued to decline.
Keep Reading →
January 13 - Market Movers, News - Comments
Sientra Inc (NASDAQ:SIEN), Select Medical Holdings Corporation (NYSE:SEM), Halozyme Therapeutics, Inc. (NASDAQ:HALO), and Micron Technology, Inc.
Keep Reading →
January 11 - Market Movers, News - Comments
How do we determine whether Halozyme Therapeutics, Inc.
Keep Reading →
December 2 - Hedge Funds, News - Comments
David Cohen and Harold Levy of Iridian Asset Management have significantly increased their stake in Halozyme Therapeutics, Inc.
Keep Reading →
June 9 - Hedge Funds, News - Comments
As a new filing with the Securities and Exchange Commission shows, Daniel Gold's QVT Financial has initiated a passive stake in Aehr Test Systems (NASDAQ:AEHR).
Keep Reading →
April 23 - Hedge Funds, News - Comments
In the world of small biotech companies, investors are always fishing for the next small fish to be gobbled up by a bigger one since the industry is well-known for its hefty acquisition...
Keep Reading →
September 16 - News - Comments
In the financial world, there are a multitude of gauges shareholders can use to analyze Mr. Market. Two of the most innovative are hedge fund and insider trading interest.
Keep Reading →
September 6 - News - Comments
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Keep Reading →
September 5 - News - Comments
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
Keep Reading →
September 4 - News - Comments
With August winding down, summer won't be around much longer. Several health-care stocks still had hot days this past week, though.
Keep Reading →
September 1 - News - Comments
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7.38% gain YTD as of Aug 2, ...
Keep Reading →
August 10 - News - Comments
One decision led to a double whammy this week for biotech companies Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Viropharma Inc (NASDAQ:VPHM).
Keep Reading →
August 5 - News - Comments
Halozyme Therapeutics, Inc. (NASDAQ:HALO) moved higher by 25% on Friday behind the news of a positive opinion by the European Medicines Agency's Committee for Medicinal Products...
Keep Reading →
July 29 - News - Comments
Xiaflex from Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) is used to treat Dupuytren’s contracture.
Keep Reading →
July 22 - News - Comments
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short.
Keep Reading →
July 2 - News - Comments
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year.
Keep Reading →
June 21 - News - Comments
To most market participants, hedge funds are viewed as underperforming, outdated financial vehicles of the past.
Keep Reading →
June 7 - News - Comments
To the average investor, there are a multitude of metrics market participants can use to track stocks. A pair of the most useful are hedge fund and insider trading movement.
Keep Reading →
June 6 - News - Comments
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment.
Keep Reading →
May 28 - News - Comments
To most traders, hedge funds are seen as unimportant, outdated investment tools of the past.
Keep Reading →
May 24 - News - Comments